Study of Efficacy and Safety of Secukinumab 2 mL Auto-injector (300 mg) in Subjects With Moderate to Severe Plaque Psoriasis
- Status
- COMPLETED
- Phase
- PHASE3
Clinical Trials Related to Novartis Pharmaceuticals
Related studies linked through entity extraction aliases.
A Phase III Study of Safety and Efficacy of Ligelizumab in the Treatment of CSU in Adolescents and Adults Inadequately Controlled With H1-antihistamines
- Status
- COMPLETED
- Phase
- PHASE3
A Phase III Study of and Efficacy of Ligelizumab in the Treatment of CSU in Adolescents and Adults Inadequately Controlled With H1-antihistamines.
- Status
- COMPLETED
- Phase
- PHASE3
Study of Efficacy and Safety of Asciminib in Combination With Imatinib in Patients With Chronic Myeloid Leukemia in Chronic Phase (CML-CP) Who Have Been Previously Treated With Imatinib and Have Not Achieved Deep Molecular Response.
- Status
- COMPLETED
- Phase
- PHASE2
Study Comparing Two VAY736 Drug Products in Patients With Rheumatoid Arthritis
- Status
- COMPLETED
- Phase
- PHASE1
Tisagenlecleucel in Adult Patients With Aggressive B-cell Non-Hodgkin Lymphoma
- Status
- COMPLETED
- Phase
- PHASE3
Efficacy and Safety of Tisagenlecleucel in Adult Patients With Refractory or Relapsed Follicular Lymphoma
- Status
- COMPLETED
- Phase
- PHASE2
Investigation of Efficacy of Secukinumab in Patients With Moderate to Serve Atopic Dermatitis
- Status
- COMPLETED
- Phase
- PHASE2
A 12 Week Randomized Open Label Parallel Group Multicenter Study to Evaluate Bioequivalence of 20 mg Subcutaneous Ofatumumab Injected by Pre-filled Syringe or Autoinjector in Adult RMS Patients
- Status
- COMPLETED
- Phase
- PHASE2
Comparison of Secukinumab Versus Guselkumab in Clearing Psoriatic Plaques Refractory to Ustekinumab
- Status
- COMPLETED
- Phase
- PHASE2
Study of Dabrafenib+Trametinib in the Adjuvant Treatment of Stage III BRAF V600+ Melanoma After Complete Resection to Evaluate the Impact on Pyrexia Related Outcomes
- Status
- COMPLETED
- Phase
- PHASE3
A Phase I/Ib Study of NZV930 Alone and in Combination With PDR001 and /or NIR178 in Patients With Advanced Malignancies.
- Status
- TERMINATED
- Phase
- PHASE1
Phase III Study of Nazartinib (EGF816) Versus Erlotinib/Gefitinib in First-line Locally Advanced / Metastatic NSCLC With EGFR Activating Mutations
- Status
- WITHDRAWN
- Phase
- PHASE3
Safety and Efficacy of Everolimus (Afinitor®) in Chinese Adult Patients With Angiomyolipoma Associated With Tuberous Sclerosis Complex.
- Status
- COMPLETED
- Phase
- PHASE4
A Study to Assess the Ability of Eltrombopag to Induce Sustained Response Off Treatment in Subjects With ITP
- Status
- COMPLETED
- Phase
- PHASE2
A Study to Assess the Safety and Efficacy of ZPL389 in Patients With Moderate to Severe Atopic Dermatitis
- Status
- TERMINATED
- Phase
- PHASE2
Study of Safety, Tolerability, and Efficacy of a Combination Treatment of LJN452 and CVC in Adult Patients With NASH and Liver Fibrosis
- Status
- COMPLETED
- Phase
- PHASE2
A Global Study of the Efficacy and Safety of Midostaurin + Chemotherapy in Newly Diagnosed Patients With FLT3 Mutation Negative (FLT3-MN) Acute Myeloid Leukemia (AML)
- Status
- COMPLETED
- Phase
- PHASE3
TCR Genetically Engineered PBMC and PBSC After Melphalan Conditioning Regimen in Treating Participants With Relapsed and Refractory Multiple Myeloma
- Status
- WITHDRAWN
- Phase
- PHASE1
Efficacy and Safety of 2 Secukinumab Regimens in 90kg or More Weight Group With Moderate/Severe Chronic Plaque Psoriasis
- Status
- COMPLETED
- Phase
- PHASE3